Vimarsana
Biggest News Aggregation in the World

Page 7 - Wockhardt Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wockhardt Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wockhardt Ltd Today - Breaking & Trending Today

Gift Nifty signals a tepid start: ITC, Vodafone Idea Q1 results; stocks in F&O ban; TVS Supply IPO & more - Vimarsana News

Gift Nifty signals a tepid start: ITC, Vodafone Idea Q1 results; stocks in F&O ban; TVS Supply IPO & more

ITC Ltd, Vodafone Idea Ltd, Indiabulls Housing Finance, KNR Constructions Ltd, AstraZeneca Pharma India, Wockhardt Ltd and Saksoft Ltd are among a handful of companies that will announce their quarterly results today.

Business News | Wockhardt Ltd Aims to Turnaround Business Operations with Restructuring of US Operations and Vaccine Tie-up with Serum - Vimarsana News

Business News | Wockhardt Ltd Aims to Turnaround Business Operations with Restructuring of US Operations and Vaccine Tie-up with Serum

Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], July 27: Wockhardt Ltd – global pharmaceutical and biotechnology is aiming to turnaround its business operations and has perused important strategic initiatives for the same. Company is eying big on the restructuring of the US Business, vaccine tie-up with Serum for vaccine manufacturing in UK and Novel Antibiotics research to drive the business forward. For the Q4FY23, company posted strong operational performance with 7% Y-o-Y growth in revenue with three fold jump in the EBITDA to Rs. 47 crore. Bus...

Bronchiectasis Drugs Market to grow by USD 326.01 million from 2022 to 2027 | Increasing cases of associated risk factors to boost the market growth - Vimarsana News

Bronchiectasis Drugs Market to grow by USD 326.01 million from 2022 to 2027 | Increasing cases of associated risk factors to boost the market growth

/PRNewswire/ -- The global bronchiectasis drugs market size is estimated to grow by USD 326.01 million from 2022 to 2027, according to Technavio. The market is...

SEBI Bans Ex-Wockhardt Executive From Securities Market For Six Months - Vimarsana News

SEBI Bans Ex-Wockhardt Executive From Securities Market For Six Months

Yatendra Kumar is also prohibited from buying, selling, or engaging in any transactions involving Wockhardt.

Source: news18.com
Wockhardt's Ex-Executive Barred From Securities Market For 6-Months For Insider Trading - Vimarsana News

Wockhardt's Ex-Executive Barred From Securities Market For 6-Months For Insider Trading

Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules.

Source: ndtv.com